STAT Signaling and Transcription

STAT (signal transducer and activator of transcription) proteins are latent cytoplasmic transcription factors that carry signals directly from cell-surface cytokine and growth-factor receptors to the nucleus. After receptor-associated Janus kinases (JAKs) phosphorylate them, STATs dimerise, enter the nucleus, and activate target genes, making the JAK-STAT route one of the most direct signal-to-transcription pathways in cell biology.

Definition

STAT signalling is a pathway in which ligand binding to a cytokine or growth-factor receptor activates receptor-associated JAK tyrosine kinases, which phosphorylate STAT proteins; phosphorylated STATs dimerise, translocate to the nucleus, and bind specific DNA elements to regulate transcription.

Scope

The entry covers the architecture of the JAK-STAT pathway, the activation cycle of STAT proteins, the gene programmes they control in immunity and growth, and how the system is regulated and goes awry in disease. It is mechanistic reference material, not clinical guidance.

Core questions

• How do receptors lacking intrinsic kinase activity transmit a signal to the nucleus?
• What confers specificity among the different STAT family members?
• How is STAT activity switched off after a response?
• Why is persistent STAT activation associated with cancer and inflammation?

Key concepts

• Latent cytoplasmic transcription factor
• Janus kinases (JAKs)
• Tyrosine phosphorylation and SH2-domain dimerisation
• Nuclear translocation and DNA binding
• Interferon and cytokine signalling
• Negative regulation by SOCS and phosphatases
• Constitutive STAT3 activation in cancer

Mechanisms

A cytokine or growth factor binds its receptor, bringing receptor chains together and activating the JAKs docked on their cytoplasmic tails. The JAKs phosphorylate tyrosine residues on the receptor and on recruited STAT proteins. Phosphorylated STATs use their SH2 domains to dimerise, translocate to the nucleus, and bind sequence-specific response elements to drive transcription of target genes (Darnell et al., 1994). This pathway underlies the cellular response to interferons and many other cytokines (Stark et al., 1998). The signal is terminated by phosphatases and by SOCS proteins induced as feedback inhibitors. Because the same logic of receptor-coupled kinase activation underlies broader growth-factor signalling, JAK-STAT is often discussed alongside receptor tyrosine kinase pathways (Lemmon & Schlessinger, 2010).

Clinical relevance

Aberrant, persistent activation of STAT proteins, particularly STAT3, is observed across many cancers and links inflammation to tumour biology (Yu et al., 2009), and inherited defects in JAK-STAT components cause immunodeficiency. This entry summarises those associations as reference knowledge; it does not provide diagnostic or treatment recommendations.

Evidence & guidelines

Understanding of STAT signalling rests on biochemical and genetic studies synthesised in major reviews; the pathway is reference science rather than the subject of clinical practice guidelines. The cited reviews summarise the consensus mechanism and its disease associations.

History

The JAK-STAT pathway was uncovered in the early 1990s through studies of how interferons induce genes, work that identified STAT proteins as the direct nuclear effectors and JAKs as the activating kinases. The framework, consolidated by Darnell, Stark, Kerr, and colleagues, quickly generalised from interferons to a wide range of cytokines and growth factors.

Key figures

• James E. Darnell
• George R. Stark
• Ian M. Kerr
• Robert D. Schreiber

Seminal works

• darnell-1994
• stark-1998
• yu-2009

Frequently asked questions

What does STAT stand for?

STAT stands for signal transducer and activator of transcription, reflecting that the same protein both relays the signal from the receptor and acts as a transcription factor in the nucleus.

How is the JAK-STAT pathway different from pathways with many intermediate steps?

It is unusually direct: the transcription factor itself is phosphorylated at the receptor and then moves straight to the nucleus, without a long cascade of separate messengers in between.